Riboflavin 5-phosphate ophthalmic
EPIOXA CROSS-LINKING is a prescription ophthalmic solution containing riboflavin 5-phosphate (0.239%) used in corneal cross-linking procedures to strengthen the cornea and treat conditions like keratoconus. It comes as a kit with syringes for eye application. Manufactured by Glaukos Corporation. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | EPIOXA CROSS-LINKING is a prescription ophthalmic solution containing riboflavin 5-phosphate (0.239%) used in corneal cross-linking procedures to strengthen the cornea and treat conditions like keratoconus. It comes as a kit with syringes for eye application. Manufactured by Glaukos Corporation. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Riboflavin 5-phosphate ophthalmic", "mediaType": "text/html", "description": " Access the FDA dataset for Riboflavin 5-phosphate ophthalmic — ANDA 219910 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219910" } ] |
| identifier | ANDA219910 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "fda", "medications", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Riboflavin 5-phosphate ophthalmic |
